These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12944136)

  • 1. In vitro iontophoretic transport of ketorolac: synthetic membrane as a barrier.
    Tiwari SB; Udupa N
    Drug Deliv; 2003; 10(3):161-8. PubMed ID: 12944136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal iontophoresis of rotigotine across human stratum corneum in vitro: influence of pH and NaCl concentration.
    Nugroho AK; Li GL; Danhof M; Bouwstra JA
    Pharm Res; 2004 May; 21(5):844-50. PubMed ID: 15180344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation into the potential of iontophoresis facilitated delivery of ketorolac.
    Tiwari SB; Udupa N
    Int J Pharm; 2003 Jul; 260(1):93-103. PubMed ID: 12818814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iontophoretic transport across a multiple membrane system.
    Molokhia SA; Zhang Y; Higuchi WI; Li SK
    J Pharm Sci; 2008 Jan; 97(1):490-505. PubMed ID: 17990310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro permeability of a model protein across ocular tissues and effect of iontophoresis on the transscleral delivery.
    Tratta E; Pescina S; Padula C; Santi P; Nicoli S
    Eur J Pharm Biopharm; 2014 Sep; 88(1):116-22. PubMed ID: 24816128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport mechanisms in iontophoresis. III. An experimental study of the contributions of electroosmotic flow and permeability change in transport of low and high molecular weight solutes.
    Pikal MJ; Shah S
    Pharm Res; 1990 Mar; 7(3):222-9. PubMed ID: 2339093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting iontophoretic mobility of metoprolol.
    Thysman S; Préat V; Roland M
    J Pharm Sci; 1992 Jul; 81(7):670-5. PubMed ID: 1403702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous metabolism of a dipeptide influences the iontophoretic flux of a concomitant uncharged permeant.
    Altenbach M; Schnyder N; Zimmermann C; Imanidis G
    Int J Pharm; 2006 Jan; 307(2):308-17. PubMed ID: 16310991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compartmental modeling of transdermal iontophoretic transport: I. In vitro model derivation and application.
    Nugroho AK; Della Pasqua O; Danhof M; Bouwstra JA
    Pharm Res; 2004 Nov; 21(11):1974-84. PubMed ID: 15587918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled transport of timolol maleate through artificial membranes under passive and iontophoretic conditions.
    Stamatialis DF; Rolevink HH; Koops GH
    J Control Release; 2002 Jun; 81(3):335-45. PubMed ID: 12044572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced transscleral lontophoretic transport with ion-exchange membrane.
    Li SK; Zhu H; Higuchi WI
    Pharm Res; 2006 Aug; 23(8):1857-67. PubMed ID: 16841198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms involved in iontophoretic transport of angiotensin.
    Clemessy M; Couarraze G; Bevan B; Puisieux F
    Pharm Res; 1995 Jul; 12(7):998-1002. PubMed ID: 7494820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of a hydroxypropyl cellulose gel system for transdermal delivery of timolol.
    Stamatialis DF; Rolevink HH; Gironès M; Nymeijer DC; Koops GH
    Curr Drug Deliv; 2004 Oct; 1(4):313-9. PubMed ID: 16305393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of asymmetric donor-receiver ion concentration upon transscleral iontophoretic transport.
    Li SK; Zhang Y; Zhu H; Higuchi WI; White HS
    J Pharm Sci; 2005 Apr; 94(4):847-60. PubMed ID: 15736190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iontophoretic enhancement of timolol across human dermatomed skin in vitro.
    Fatouros DG; Bouwstra JA
    J Drug Target; 2004 Jan; 12(1):19-24. PubMed ID: 15203908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of electrical and chemical factors on transdermal iontophoretic delivery of three diclofenac salts.
    Fang JY; Wang RJ; Huang YB; Wu PC; Tsai YH
    Biol Pharm Bull; 2001 Apr; 24(4):390-4. PubMed ID: 11305601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketorolac-dextran conjugates: synthesis, in vitro and in vivo evaluation.
    Vyas S; Trivedi P; Chaturvedi SC
    Acta Pharm; 2007 Dec; 57(4):441-50. PubMed ID: 18165188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transscleral passive and iontophoretic transport: theory and analysis.
    Li SK; Hao J
    Expert Opin Drug Deliv; 2018 Mar; 15(3):283-299. PubMed ID: 29149574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.